Reply to: "NAFLD is a predictor of liver injury in COVID-19 hospitalized patients but not of mortality, disease severity on the presentation or progression - The debate continues"
J Hepatol. 2021 Feb;74(2):484-485.
doi: 10.1016/j.jhep.2020.10.020.
Epub 2020 Oct 29.
1 The Fifth Medical Center of Chinese PLA General Hospital, Beijing 100039, China.
2 Faculty of Health Science, University of Macau; Humanity and Health Clinical Trial Center, Humanity & Health Medical Group, Hong Kong SAR, China.
3 The Fifth Medical Center of Chinese PLA General Hospital, Beijing 100039, China; Humanity and Health Clinical Trial Center, Humanity & Health Medical Group, Hong Kong SAR, China. Electronic address: gkklau@hnhmgl.com.